These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10370204)

  • 1. Ocular devices for the controlled systemic delivery of insulin: in vitro and in vivo dissolution.
    Lee YC; Yalkowsky SH
    Int J Pharm; 1999 Apr; 181(1):71-7. PubMed ID: 10370204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of formulation on the systemic absorption of insulin from enhancer-free ocular devices.
    Lee YC; Yalkowsky SH
    Int J Pharm; 1999 Aug; 185(2):199-204. PubMed ID: 10460915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic absorption of insulin from a Gelfoam ocular device.
    Lee Y; Yalkowsky SH
    Int J Pharm; 1999 Nov; 190(1):35-40. PubMed ID: 10528094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of insulin via an enhancer-free ocular device.
    Lee YC; Simamora P; Yalkowsky SH
    J Pharm Sci; 1997 Dec; 86(12):1361-4. PubMed ID: 9423146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular device for the controlled systemic delivery of insulin.
    Simamora P; Lee YC; Yalkowsky SH
    J Pharm Sci; 1996 Oct; 85(10):1128-30. PubMed ID: 8897284
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Brij-78 on systemic delivery of insulin from an ocular device.
    Lee YC; Simamora P; Yalkowsky SH
    J Pharm Sci; 1997 Apr; 86(4):430-3. PubMed ID: 9109043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid.
    Agarwal V; Nazzal S; Khan MA
    Pharm Dev Technol; 2008; 13(4):291-8. PubMed ID: 18618331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intelligent polymeric systems for glucose-responsive insulin delivery].
    Qu J; Chu L; Li Y; Chen W; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1028-30. PubMed ID: 15646358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible pegylation of insulin facilitates its prolonged action in vivo.
    Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
    Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide.
    Lee YC; Millard J; Negvesky GJ; Butrus SI; Yalkowsky SH
    Int J Pharm; 1999 May; 182(1):121-6. PubMed ID: 10332081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and in vivo evaluation of a patch delivery system for insulin based on thiolated polymers.
    Grabovac V; Föger F; Bernkop-Schnürch A
    Int J Pharm; 2008 Feb; 348(1-2):169-74. PubMed ID: 17706903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: application for the subcutaneous injection in rats.
    Nishimura A; Hayakawa T; Yamamoto Y; Hamori M; Tabata K; Seto K; Shibata N
    Eur J Pharm Sci; 2012 Jan; 45(1-2):1-7. PubMed ID: 22064453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of acid/base nature and molecular weight in drug release from matrices of gelfoam and monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride).
    Hämäläinen KM; Määttä E; Piirainen H; Marianne Sarkola ; Väisänen A; Ranta VP; Urtti A
    J Control Release; 1998 Dec; 56(1-3):273-83. PubMed ID: 9801450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of systemic regular insulin via the ocular route in cats.
    Morgan RV
    J Ocul Pharmacol Ther; 1995; 11(4):565-73. PubMed ID: 8574820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of insulin from injectable biodegradable triblock copolymer depot in ZDF rats.
    Choi S; Kim SW
    Pharm Res; 2003 Dec; 20(12):2008-10. PubMed ID: 14725367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained insulin release with biodegradation of chitosan gel beads prepared by copper ions.
    Kofuji K; Murata Y; Kawashima S
    Int J Pharm; 2005 Oct; 303(1-2):95-103. PubMed ID: 16139972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.